| Name | Polaryx Therapeutics, Inc. |
|---|---|
| CIK | 0002075320 |
| Tickers | PLYX |
| Exchanges | Nasdaq |
| Entity type | operating |
| Category | Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company |
| SIC | 2834 Pharmaceutical Preparations |
| EIN | 000000000 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | WY WY |
| Phone | 201-940-7236 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
No Financialist filing articles yet for this CIK.
36 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-12 | 10-Q | QUARTERLY REPORT | 0001213900-26-118950 | 001-43080 | 261547205 | 34 | 3614735 | 1 | 1 | |
| 2026-09-14 | 8-K | CURRENT REPORT | 5.07 | 0001213900-26-099416 | 001-43080 | 261375592 | 34 | 197001 | 1 | 1 |
| 2026-09-01 | 8-K | CURRENT REPORT | 7.01,8.01,9.01 | 0001213900-26-096235 | 001-43080 | 261351244 | 34 | 218058 | 1 | 1 |
| 2026-08-13 | 10-Q | QUARTERLY REPORT | 0001213900-26-089118 | 001-43080 | 261273630 | 34 | 3619479 | 1 | 1 | |
| 2026-07-28 | ARS | ARS | 0001213900-26-082353 | 001-43080 | 261212856 | 34 | 5321989 | |||
| 2026-07-28 | DEFA14A | DEFINITIVE ADDITIONAL MATERIALS | 0001213900-26-082345 | 001-43080 | 261212823 | 34 | 2095202 | |||
| 2026-07-28 | DEF 14A | PROXY STATEMENT | 0001213900-26-082339 | 001-43080 | 261212804 | 34 | 6198757 | 1 | 1 | |
| 2026-07-24 | S-8 | REGISTRATION STATEMENT | 0001213900-26-081404 | 333-297686 | 261201852 | 33 | 193953 | 1 | 1 | |
| 2026-07-21 | 8-K | CURRENT REPORT | 5.02 | 0001213900-26-080041 | 001-43080 | 261190580 | 34 | 191540 | 1 | 1 |
| 2026-07-17 | 8-K | CURRENT REPORT | 5.08,8.01 | 0001213900-26-078912 | 001-43080 | 261181884 | 34 | 193280 | 1 | 1 |
| 2026-05-28 | 4 | xslF345X06/ownership.xml | 0001213900-26-062322 | 7516 | ||||||
| 2026-05-28 | 8-K | CURRENT REPORT | 1.01,3.02,7.01,9.01 | 0001213900-26-062155 | 001-43080 | 261036782 | 34 | 275068 | 1 | 1 |
| 2026-05-15 | 10-Q | QUARTERLY REPORT | 0001213900-26-056973 | 001-43080 | 26981485 | 34 | 3321075 | 1 | 1 | |
| 2026-03-24 | 10-K | ANNUAL REPORT | 0001213900-26-033064 | 001-43080 | 26783579 | 34 | 30776746 | 1 | 1 | |
| 2026-02-20 | 4 | xslF345X05/ownership.xml | 0001213900-26-018845 | 4549 | ||||||
| 2026-02-05 | SCHEDULE 13D | xslSCHEDULE_13D_X01/primary_doc.xml | 0001213900-26-012759 | 005-95464 | 26602866 | 34 | 21980 | |||
| 2026-02-02 | 424B4 | PROSPECTUS | 0001213900-26-010761 | 333-291681 | 26587845 | 33 | 24368380 | |||
| 2026-01-29 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-26-000339 | 333-291681 | 26580279 | 33 | 1792 | ||
| 2026-01-29 | 3 | OWNERSHIP DOCUMENT | 0001213900-26-009664 | 16281 | ||||||
| 2026-01-29 | 3 | OWNERSHIP DOCUMENT | 0001213900-26-009569 | 9673 | ||||||
| 2026-01-29 | 3 | OWNERSHIP DOCUMENT | 0001213900-26-009567 | 10997 | ||||||
| 2026-01-29 | 3 | OWNERSHIP DOCUMENT | 0001213900-26-009566 | 11028 | ||||||
| 2026-01-29 | 3 | OWNERSHIP DOCUMENT | 0001213900-26-009565 | 9754 | ||||||
| 2026-01-29 | 3 | OWNERSHIP DOCUMENT | 0001213900-26-009564 | 11127 | ||||||
| 2026-01-29 | 3 | OWNERSHIP DOCUMENT | 0001213900-26-009563 | 9693 | ||||||
| 2026-01-28 | CERT | PLYX_8A_Cert_2075320.pdf | 0001354457-26-000098 | 001-43080 | 26570683 | 34 | 113451 | |||
| 2026-01-27 | 8-A12B | FOR REGISTRATION OF CERTAIN CLASSES | 0001213900-26-008173 | 001-43080 | 26564500 | 34 | 21407 | |||
| 2026-01-27 | S-1/A | REGISTRATION STATEMENT | 0001213900-26-007973 | 333-291681 | 26562086 | 33 | 24823689 | 1 | 1 | |
| 2026-01-14 | S-1/A | REGISTRATION STATEMENT | 0001213900-26-004079 | 333-291681 | 26531194 | 33 | 24879565 | |||
| 2025-11-21 | S-1 | REGISTRATION STATEMENT | 0001213900-25-113249 | 333-291681 | 251504340 | 33 | 25515488 | 1 | 1 | |
| 2025-10-31 | C-U | xslC_X01/primary_doc.xml | 0001213900-25-104723 | 020-36323 | 251441064 | 33 | 10687 | |||
| 2025-10-27 | C-U | xslC_X01/primary_doc.xml | 0001213900-25-102529 | 020-36323 | 251419400 | 33 | 10671 | |||
| 2025-10-01 | C/A | xslC_X01/primary_doc.xml | 0001213900-25-094743 | 020-36323 | 251365293 | 33 | 11658058 | |||
| 2025-09-19 | DRS/A | filename1.htm | 0001213900-25-089144 | 377-08292 | 251324657 | 33 | 24548959 | |||
| 2025-09-03 | C | xslC_X01/primary_doc.xml | 0001213900-25-084152 | 020-36323 | 251291105 | 33 | 11431403 | |||
| 2025-08-05 | DRS | filename1.htm | 0001213900-25-072048 | 377-08292 | 251184648 | 33 | 24013042 |
One latest value per concept from companyfacts (103 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 49.85M | 2026-10-31 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118950 | |
| dei | EntityPublicFloat | Entity Public Float | USD | 0 | 2025-06-30 | 2025 | FY | 10-K | 2026-03-24 | 0001213900-26-033064 | |
| ffd | NetFeeAmt | NetFeeAmt | USD | 1,196.3 | 2026-07-15 | S-8 | 2026-07-24 | 0001213900-26-081404 | |||
| ffd | TtlFeeAmt | TtlFeeAmt | USD | 1,196.3 | 2026-07-15 | S-8 | 2026-07-24 | 0001213900-26-081404 | |||
| ffd | TtlOfferingAmt | TtlOfferingAmt | USD | 8.66M | 2026-07-15 | S-8 | 2026-07-24 | 0001213900-26-081404 | |||
| ffd | TtlOffsetAmt | TtlOffsetAmt | USD | 0 | 2026-07-15 | S-8 | 2026-07-24 | 0001213900-26-081404 | |||
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 783,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118950 | |
| us-gaap | AccruedLiabilitiesAndOtherLiabilities | Accrued Liabilities and Other Liabilities | USD | 52,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118950 | |
| us-gaap | AccruedLiabilitiesCurrent | Accrued Liabilities, Current | USD | 23,000 | 2025-12-31 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118950 | |
| us-gaap | AdditionalPaidInCapital | Additional Paid in Capital | USD | 114.49M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118950 | |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue | APIC, Share-based Payment Arrangement, Increase for Cost Recognition | USD | 467,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118950 |
| us-gaap | AllocatedShareBasedCompensationExpense | Share-based Payment Arrangement, Expense | USD | 467,000 | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-15 | 0001213900-26-056973 |
| us-gaap | AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 4.04M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118950 |
| us-gaap | Assets | Assets | USD | 8.61M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118950 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 8.61M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118950 | |
| us-gaap | Cash | Cash | USD | 250,000 | 2025-01-31 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118950 | |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 8.44M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118950 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | USD | 8.44M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118950 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect | USD | 3.30M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118950 |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118950 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 560.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118950 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 49.85M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118950 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 49.85M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118950 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 5,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118950 | |
| us-gaap | CostsAndExpensesRelatedParty | Costs and Expenses, Related Party | USD | 90,000 | 2026-03-01 | 2026-03-31 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118950 |
| us-gaap | DeferredTaxAssetsGross | Deferred Tax Assets, Gross | USD | 6.64M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-24 | 0001213900-26-033064 | |
| us-gaap | DeferredTaxAssetsInProcessResearchAndDevelopment | Deferred Tax Assets, in Process Research and Development | USD | 998,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-24 | 0001213900-26-033064 | |
| us-gaap | DeferredTaxAssetsNet | Deferred Tax Assets, Net of Valuation Allowance | USD | 250,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-24 | 0001213900-26-033064 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwards | Deferred Tax Assets, Operating Loss Carryforwards | USD | 4.74M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-24 | 0001213900-26-033064 | |
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwards | Deferred Tax Assets, Tax Credit Carryforwards | USD | 50,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-24 | 0001213900-26-033064 | |
| us-gaap | DeferredTaxAssetsValuationAllowance | Deferred Tax Assets, Valuation Allowance | USD | 6.39M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-24 | 0001213900-26-033064 | |
| us-gaap | DeferredTaxLiabilities | Deferred Tax Liabilities, Net | USD | 250,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-24 | 0001213900-26-033064 | |
| us-gaap | DeferredTaxLiabilitiesOther | Deferred Tax Liabilities, Other | USD | 250,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-24 | 0001213900-26-033064 | |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | -0.15 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118950 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | -0.15 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118950 |
| us-gaap | EffectiveIncomeTaxRateContinuingOperations | Effective Income Tax Rate Reconciliation, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-24 | 0001213900-26-033064 |
| us-gaap | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | pure | 0.21 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-24 | 0001213900-26-033064 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent | pure | -0.186 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-24 | 0001213900-26-033064 |
| us-gaap | EffectiveIncomeTaxRateReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent | pure | -0.027 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-24 | 0001213900-26-033064 |
| us-gaap | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-24 | 0001213900-26-033064 |
| us-gaap | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-24 | 0001213900-26-033064 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCredits | Effective Income Tax Rate Reconciliation, Tax Credit, Percent | pure | 0.004 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-24 | 0001213900-26-033064 |
| us-gaap | EmployeeRelatedLiabilitiesCurrent | Employee-related Liabilities, Current | USD | 18,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118950 | |
| us-gaap | EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount | USD | 7.20M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118950 | |
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 2.82M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118950 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic | Income (Loss) from Continuing Operations before Income Taxes, Domestic | USD | -8.98M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-24 | 0001213900-26-033064 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | USD | -8.98M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-24 | 0001213900-26-033064 |
| us-gaap | IncreaseDecreaseInAccountsPayable | Increase (Decrease) in Accounts Payable | USD | 313,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118950 |
| us-gaap | IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities | USD | 31,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118950 |
| us-gaap | IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets | Increase (Decrease) in Prepaid Expense and Other Assets | USD | 143,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118950 |
| us-gaap | InvestmentCompanyIssuanceOfSharesPerShare | InvestmentCompanyIssuanceOfSharesPerShare | USD/shares | 1.78 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118950 |
| us-gaap | InvestmentOwnedAtCost | Investment Owned, at Cost | USD | 10.00M | 2026-05-31 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001213900-26-089118 | |
| us-gaap | InvestmentOwnedAtFairValue | Investment Owned, at Fair Value | USD | 10.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118950 | |
| us-gaap | InvestmentOwnedPercentOfNetAssets | Investment Owned, Percent of Net Assets | pure | 0.05 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118950 | |
| us-gaap | Liabilities | Liabilities | USD | 999,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118950 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 8.61M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118950 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 999,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118950 | |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 9.83M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118950 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -6.53M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118950 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -7.25M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118950 |
| us-gaap | NetIncomeLossAvailableToCommonStockholdersBasic | Net Income (Loss) Available to Common Stockholders, Basic | USD | -7.25M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118950 |
| us-gaap | NetIncomeLossAvailableToCommonStockholdersDiluted | Net Income (Loss) Available to Common Stockholders, Diluted | USD | -7.25M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118950 |
| us-gaap | NoninterestExpenseInvestmentAdvisoryFees | Noninterest Expense Investment Advisory Fees | USD | 467,000 | 2024-10-01 | 2024-10-31 | 2025 | FY | 10-K | 2026-03-24 | 0001213900-26-033064 |
| us-gaap | NoninterestExpenseOfferingCost | Noninterest Expense Offering Cost | USD | 5.00M | 2025-09-03 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118950 | |
| us-gaap | NumberOfOperatingSegments | Number of Operating Segments | Segment | 1 | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-15 | 0001213900-26-056973 |
| us-gaap | NumberOfReportableSegments | Number of Reportable Segments | Segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118950 |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 6.67M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118950 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -6.67M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118950 |
| us-gaap | OperatingLossCarryforwards | Operating Loss Carryforwards | USD | 18.70M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-24 | 0001213900-26-033064 | |
| us-gaap | OperatingLossCarryforwardsValuationAllowance | Operating Loss Carryforwards, Valuation Allowance | USD | 1.50M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-24 | 0001213900-26-033064 | |
| us-gaap | OtherAccruedLiabilitiesCurrent | Other Accrued Liabilities, Current | USD | 21,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-24 | 0001213900-26-033064 | |
| us-gaap | OtherAssetsCurrent | Other Assets, Current | USD | 18,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118950 | |
| us-gaap | OtherExpenses | Other Expenses | USD | 26.00M | 2024-02-01 | 2024-02-29 | 2025 | FY | 10-K | 2026-03-24 | 0001213900-26-033064 |
| us-gaap | PaymentsOfStockIssuanceCosts | Payments of Stock Issuance Costs | USD | 169,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118950 |
| us-gaap | PreferredStockParOrStatedValuePerShare | Preferred Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118950 | |
| us-gaap | PreferredStockSharesAuthorized | Preferred Stock, Shares Authorized | shares | 40.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118950 | |
| us-gaap | PreferredStockSharesIssued | Preferred Stock, Shares Issued | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118950 | |
| us-gaap | PreferredStockSharesOutstanding | Preferred Stock, Shares Outstanding | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118950 | |
| us-gaap | PrepaidExpenseCurrent | Prepaid Expense, Current | USD | 152,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118950 | |
| us-gaap | ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock | USD | 10.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118950 |
| us-gaap | ProceedsFromRelatedPartyDebt | Proceeds from Related Party Debt | USD | 65,000 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-24 | 0001213900-26-033064 |
| us-gaap | RelatedPartyTransactionAmountsOfTransaction | Related Party Transaction, Amounts of Transaction | USD | 20,000 | 2026-01-31 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118950 | |
| us-gaap | RepaymentsOfRelatedPartyDebt | Repayments of Related Party Debt | USD | 193,000 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-24 | 0001213900-26-033064 |
| us-gaap | ResearchAndDevelopmentExpense | Research and Development Expense | USD | 3.85M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118950 |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -106.89M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118950 | |
| us-gaap | SaleOfStockNumberOfSharesIssuedInTransaction | Sale of Stock, Number of Shares Issued in Transaction | shares | 2.50M | 2026-05-01 | 2026-05-31 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118950 |
| us-gaap | SaleOfStockPricePerShare | Sale of Stock, Price Per Share | USD/shares | 4 | 2026-05-31 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118950 | |
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 467,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118950 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage | Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage | pure | 0.5 | 2024-10-18 | 2025 | FY | 10-K | 2026-03-24 | 0001213900-26-033064 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period | shares | 150,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118950 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period | shares | 2.09M | 2025-01-01 | 2025-12-31 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118950 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value | USD/shares | 1.85 | 2025-01-01 | 2025-12-31 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118950 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number | shares | 4.04M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118950 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value | USD | 5.60M | 2023-05-01 | 2023-05-31 | 2025 | FY | 10-K | 2026-03-24 | 0001213900-26-033064 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardPercentageOfOutstandingStockMaximum | Share-based Compensation Arrangement by Share-based Payment Award, Percentage of Outstanding Stock Maximum | pure | 0.15 | 2025-07-01 | 2025-08-29 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118950 |
| us-gaap | SharesIssuedPricePerShare | Shares Issued, Price Per Share | USD/shares | 1.17 | 2025-01-31 | 2025 | FY | 10-K | 2026-03-24 | 0001213900-26-033064 | |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | 7.61M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118950 | |
| us-gaap | StockIssuedDuringPeriodSharesIssuedForServices | Stock Issued During Period, Shares, Issued for Services | shares | 1.25M | 2023-05-01 | 2023-05-31 | 2025 | FY | 10-K | 2026-03-24 | 0001213900-26-033064 |
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | 9.83M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118950 |
| us-gaap | StockIssuedDuringPeriodValueOther | Stock Issued During Period, Value, Other | USD | 26.00M | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-03-24 | 0001213900-26-033064 |
| us-gaap | TaxCreditCarryforwardAmount | Tax Credit Carryforward, Amount | USD | 50,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-24 | 0001213900-26-033064 | |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 48.46M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118950 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 48.46M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-12 | 0001213900-26-118950 |